Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)	Clinical High Risk Syndrome of Psychosis	Active, not recruiting	Phase 3	2026-06-03		NCT03932136

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangzhou Psychiatric Hospital	5
Second Xiangya Hospital of Central South University	95
Shanghai Jiao Tong University School of Medicine	117
Shanghai Pudong New Area Nanhui Mental Health Center	1
Shanghai Xuhui District Mental Health Center	1
Shenzhen Fushan Biotech Co., Ltd.	1
Shenzhen Kangning Hospital	4
Suzhou Psychiatric Hospital	2
The First Affiliated Hospital of Zhengzhou University	203
Tianjin Anding Hospital	11

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guangzhou Psychiatric Hospital	Guangzhou	China	1
Second Xiangya Hospital of Central South University	Changsha	China	1
Shanghai Mental Health Center	Shanghai	China	35
Shanghai Pudong Nanhui Mental Health Center	Shanghai	China	1
Shanghai Xuhui District Mental Health Center	Shanghai	China	1
Shenzhen Kangning Hospital	Shenzhen	China	1
Suzhou Psychiatric Hospital	Suzhou	China	1
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
Tianjin Anding Hospital	Tianjin	China	1